Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Tracking CRE

Tracking CRE Infections

	CDC Vital Signs. Learn vital information about stopping C. difficile infections. Read CDC Vital SignsCDC is working to better understand the true number of infections caused by these organisms in the US. CRE infections are not a nationally notifiable condition. Therefore, there is not a requirement to report to CDC. CDC collects information on CRE from two surveillance systems:

Emerging Infections Program (EIP)
Healthcare Associated Infections Community Interface (HAIC) uses 10 sites across the country to determine which patients and community members have or are at risk for CRE and Acinetobacter.

National Healthcare Safety Network (NHSN) – tracks healthcare–associated infections of over 17,000 facilities nationwide.

CRE Definition

Patients with NDM-producing Carbapenem-resistant Enterobacteriaceae (CRE) reported to the Centers for Disease Control and Prevention (CDC) as of April 2016, by state

Patients with OXA-48-Type-producing Carbapenem-resistant Enterobacteriaceae (CRE) reported to the Centers for Disease Control and Prevention (CDC) as of April 2016, by state

Patients with VIM-producing Carbapenem-resistant Enterobacteriaceae (CRE) reported to the Centers for Disease Control and Prevention (CDC) as of April 2016, by state

Patients with KPC-producing Carbapenem-resistant Enterobacteriaceae (CRE) reported to the Centers for Disease Control and Prevention (CDC) as of February 2016, by state

Patients with IMP-producing Carbapenem-resistant Enterobacteriaceae (CRE) reported to the Centers for Disease Control and Prevention (CDC) as of April 2016, by state

	Patients with IMP-producing Carbapenem-resistant Enterobacteriaceae (CRE) reported to the Centers for Disease Control and Prevention (CDC) as of April 2016, by state

Top